Marvell Technology (MRVL) Financial statements
Company Profile
| Feb 2025 | Feb 2024 | Jan 2023 | Jan 2022 | ||
|---|---|---|---|---|---|
| Total Revenue | |||||
| Cost of Revenue | |||||
| Gross Profit | |||||
| Gross Profit Margin (%) | |||||
| R&D Expense | |||||
| SG&A Expense | |||||
| Total Operating Expenses | |||||
| Operating Income or Loss | |||||
| Operating Margin (%) | |||||
| Interest Expense | |||||
| Total Other Income/Expenses | |||||
| Income Before Tax | |||||
| Income Tax Expense | |||||
| Income from Continuing Ops. | |||||
| Net Income | |||||
| Net Profit Margin (%) | |||||
| Net Income Available to Common Shareholders | |||||
| Basic EPS | |||||
| Diluted EPS | |||||
| Basic Average Shares | |||||
| Diluted Average Shares |
| Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | May 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit Margin (%) | |||||||||||||||||||
| R&D Expense | |||||||||||||||||||
| SG&A Expense | |||||||||||||||||||
| Total Operating Expenses | |||||||||||||||||||
| Operating Income or Loss | |||||||||||||||||||
| Operating Margin (%) | |||||||||||||||||||
| Interest Expense | |||||||||||||||||||
| Total Other Income/Expenses | |||||||||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income from Continuing Ops. | |||||||||||||||||||
| Net Income | |||||||||||||||||||
| Net Profit Margin (%) | |||||||||||||||||||
| Net Income Available to Common Shareholders | |||||||||||||||||||
| Basic EPS | |||||||||||||||||||
| Diluted EPS | |||||||||||||||||||
| Basic Average Shares | |||||||||||||||||||
| Diluted Average Shares |
| Feb 2025 | Feb 2024 | Jan 2023 | Jan 2022 | ||
|---|---|---|---|---|---|
| Current Assets | |||||
| Cash & Cash Equivalents | |||||
| Marketable Securities | |||||
| Receivables | |||||
| Inventories | |||||
| Other Current Assets | |||||
| Total Current Assets | |||||
| Non-Current Assets | |||||
| Marketable Securities | |||||
| PPE Net | |||||
| Intangibles inc. Goodwill | |||||
| Other Non-Current Assets | |||||
| Total Non-Current Assets | |||||
| Total Assets | |||||
| Current Liabilities | |||||
| Accounts Payable | |||||
| Deferred Revenues | |||||
| Debt, Current | |||||
| Accrued Liabilities | |||||
| Other Current Liabilities | |||||
| Total Current Liabilities | |||||
| Non-Current Liabilities | |||||
| Deferred Revenues | |||||
| Debt, Non-Current | |||||
| Other Non-Current Liabilities | |||||
| Total Non-Current Liabilities | |||||
| Total Liabilities | |||||
| Shareholders' Equity | |||||
| Common Stock | |||||
| Additional Paid-In Capital | |||||
| Retained Earnings | |||||
| Other Shareholders' Equity | |||||
| Total Shareholders' Equity | |||||
| Total Liabilities & Shareholders' Equity |
| Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | May 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||||||||||||
| Cash & Cash Equivalents | |||||||||||||||||||
| Marketable Securities | |||||||||||||||||||
| Receivables | |||||||||||||||||||
| Inventories | |||||||||||||||||||
| Other Current Assets | |||||||||||||||||||
| Total Current Assets | |||||||||||||||||||
| Non-Current Assets | |||||||||||||||||||
| Marketable Securities | |||||||||||||||||||
| PPE Net | |||||||||||||||||||
| Intangibles inc. Goodwill | |||||||||||||||||||
| Other Non-Current Assets | |||||||||||||||||||
| Total Non-Current Assets | |||||||||||||||||||
| Total Assets | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Accounts Payable | |||||||||||||||||||
| Deferred Revenues | |||||||||||||||||||
| Debt, Current | |||||||||||||||||||
| Accrued Liabilities | |||||||||||||||||||
| Other Current Liabilities | |||||||||||||||||||
| Total Current Liabilities | |||||||||||||||||||
| Non-Current Liabilities | |||||||||||||||||||
| Deferred Revenues | |||||||||||||||||||
| Debt, Non-Current | |||||||||||||||||||
| Other Non-Current Liabilities | |||||||||||||||||||
| Total Non-Current Liabilities | |||||||||||||||||||
| Total Liabilities | |||||||||||||||||||
| Shareholders' Equity | |||||||||||||||||||
| Common Stock | |||||||||||||||||||
| Additional Paid-In Capital | |||||||||||||||||||
| Retained Earnings | |||||||||||||||||||
| Other Shareholders' Equity | |||||||||||||||||||
| Total Shareholders' Equity | |||||||||||||||||||
| Total Liabilities & Shareholders' Equity |
| Feb 2025 | Feb 2024 | Jan 2023 | Jan 2022 | ||
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net Income | |||||
| Depreciation & Amortization | |||||
| Deferred Income Taxes | |||||
| Stock Based Compensation | |||||
| Accounts Receivable | |||||
| Inventory | |||||
| Accounts Payable | |||||
| Deferred Revenue | |||||
| Other Non-Cash | |||||
| Operating Cash Flow | |||||
| Cash Flows from Investing Activities | |||||
| PPE Investments | |||||
| Net Acquisitions | |||||
| Purchase of Investments | |||||
| Sale of Investments | |||||
| Other Investing Activity | |||||
| Investing Cash Flow | |||||
| Cash Flows from Financing Activities | |||||
| Debt Issued | |||||
| Proceeds from Debt Repayment | |||||
| Debt Repayment | |||||
| Proceeds from Sale of Equity | |||||
| Equity Repurchased | |||||
| Dividend Paid | |||||
| Other Financing Activity | |||||
| Financing Cash Flow | |||||
| Cash Position | |||||
| Beginning Cash Position | |||||
| End Cash Position | |||||
| Change in Cash | |||||
| Free Cash Flow | |||||
| Operating Cash Flow | |||||
| Capital Expenditure | |||||
| Free Cash Flow |
| Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | May 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||||||||||||||||
| Net Income | |||||||||||||||||||
| Depreciation & Amortization | |||||||||||||||||||
| Deferred Income Taxes | |||||||||||||||||||
| Stock Based Compensation | |||||||||||||||||||
| Accounts Receivable | |||||||||||||||||||
| Inventory | |||||||||||||||||||
| Accounts Payable | |||||||||||||||||||
| Deferred Revenue | |||||||||||||||||||
| Other Non-Cash | |||||||||||||||||||
| Operating Cash Flow | |||||||||||||||||||
| Cash Flows from Investing Activities | |||||||||||||||||||
| PPE Investments | |||||||||||||||||||
| Net Acquisitions | |||||||||||||||||||
| Purchase of Investments | |||||||||||||||||||
| Sale of Investments | |||||||||||||||||||
| Other Investing Activity | |||||||||||||||||||
| Investing Cash Flow | |||||||||||||||||||
| Cash Flows from Financing Activities | |||||||||||||||||||
| Debt Issued | |||||||||||||||||||
| Proceeds from Debt Repayment | |||||||||||||||||||
| Debt Repayment | |||||||||||||||||||
| Proceeds from Sale of Equity | |||||||||||||||||||
| Equity Repurchased | |||||||||||||||||||
| Dividend Paid | |||||||||||||||||||
| Other Financing Activity | |||||||||||||||||||
| Financing Cash Flow | |||||||||||||||||||
| Cash Position | |||||||||||||||||||
| Beginning Cash Position | |||||||||||||||||||
| End Cash Position | |||||||||||||||||||
| Change in Cash | |||||||||||||||||||
| Free Cash Flow | |||||||||||||||||||
| Operating Cash Flow | |||||||||||||||||||
| Capital Expenditure | |||||||||||||||||||
| Free Cash Flow |